Advertisement
Advertisement
DMAA
D
Drugs Made In America Acquisition Corp. Ordinary Shares
10.51
USDSponsored
0.00
-0.01%
Mar 27, 09:30 UTC -4
Open
DMAA Earnings Reports
Positive Surprise Ratio
No Data Available for DMAA
0%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
--
/--
Drugs Made In America Acquisition Corp. Ordinary Shares earnings per share and revenue
On Mar 18, 2026, DMAA reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bobs Discount Furniture, Inc.
Report Date
Mar 17, 2026 For Q4 25
Estimate
$0.25
Actual
$0.35
Surprise
+35.71%
Public Policy Holding Company, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.65
Actual
$0.79
Surprise
+20.34%
Brazil Potash Corp.
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.07
Surprise
-15.51%
WW International, Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$1.24
Actual
-$0.44
Surprise
+64.55%
Blaize Holdings, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.14
Surprise
+31.37%
Health In Tech, Inc. Class A Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.01
Actual
-$0.01
Surprise
+0.99%
York Space Systems Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.23
Actual
-$0.28
Surprise
-25.81%
XOMA Royalty Corporation Depositary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.15
Actual
$0.26
Surprise
+264.45%
FAQ
What were Drugs Made In America Acquisition Corp. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Drugs Made In America Acquisition Corp. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Drugs Made In America Acquisition Corp. Ordinary Shares's Q4 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Drugs Made In America Acquisition Corp. Ordinary Shares expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Drugs Made In America Acquisition Corp. Ordinary Shares's next earnings report?
Based on --
analysts, Drugs Made In America Acquisition Corp. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement